On March 31, 2016, the Competition Bureau (Bureau) released further updated Intellectual Property Enforcement Guidelines (IPEGs) (Announcement) following an extensive public consultation process held in 2015. The updated IPEGs provide clarification on the Bureau’s approach to conducting investigations of alleged anti-competitive activities that relate to intellectual property. The main revisions include clarification of the Bureau’s position on patent settlements and product switching, both affecting the pharmaceutical industry. The updated IPEGs also address the conduct of patent assertion entities and conduct involving standard essential patent owners.
The E-TIPS® newsletter previously reported on an earlier version of the IPEGs here.
E-TIPS® ISSUE
Disclaimer: This Newsletter is intended to provide readers with general information on legal developments in the areas of e-commerce, information technology and intellectual property. It is not intended to be a complete statement of the law, nor is it intended to provide legal advice. No person should act or rely upon the information contained in this newsletter without seeking legal advice.
E-TIPS is a registered trade-mark of Deeth Williams Wall LLP.
